SESSION TITLE: Interventional Pulmonary Procedural Safety and Outcomes
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Wednesday, October 26, 2016 at 02:45 PM - 04:15 PM
PURPOSE: Hepatic hydrothorax refractory to salt/fluid restriction and diuretic therapy happens in 21-26% of cirrhotic patients in whom trans-jugular intrahepatic porto-systemic shunt (TIPS) and liver transplantation are not always available or indicated. These patients are therefore offered repeated thoracenteses for symptom control but the risk profile for such a management strategy remains unclear. In this retrospective study, we report on the complications of repeated thoracenteses in cirrhotic patients with hepatic hydrothorax.